San Diego-centered Viking Therapeutics marked alone as a significant competitor from the weight loss drug market place in February right after revealing promising details from the mid-phase demo of experimental drug VK2735, which advised it rivaled—and outperformed—Novo and Lilly drugs when given being a weekly injection and in March the compan